These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 19811945)
1. Caring for Machado-Joseph disease: current understanding and how to help patients. D'Abreu A; França MC; Paulson HL; Lopes-Cendes I Parkinsonism Relat Disord; 2010 Jan; 16(1):2-7. PubMed ID: 19811945 [TBL] [Abstract][Full Text] [Related]
2. Parkinsonian phenotype in Machado-Joseph disease (MJD/SCA3): a two-case report. Bettencourt C; Santos C; Coutinho P; Rizzu P; Vasconcelos J; Kay T; Cymbron T; Raposo M; Heutink P; Lima M BMC Neurol; 2011 Oct; 11():131. PubMed ID: 22023810 [TBL] [Abstract][Full Text] [Related]
3. Machado-Joseph disease/spinocerebellar ataxia type 3. Paulson H Handb Clin Neurol; 2012; 103():437-49. PubMed ID: 21827905 [TBL] [Abstract][Full Text] [Related]
4. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD. Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414 [TBL] [Abstract][Full Text] [Related]
5. [Polyglutamine-expanded ataxin-3 is degraded by autophagy]. Xiao H; Tang J; Hu Z; Tan J; Tang B; Jiang Z Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):23-8. PubMed ID: 20140862 [TBL] [Abstract][Full Text] [Related]
6. [Recent advances in molecular genetics of spinocerebellar ataxia type 3/Machado-Joseph disease]. Jia D; Jiang H; Tang B Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):660-2. PubMed ID: 19065526 [TBL] [Abstract][Full Text] [Related]
7. APOE ε2 allele may decrease the age at onset in patients with spinocerebellar ataxia type 3 or Machado-Joseph disease from the Chinese Han population. Peng H; Wang C; Chen Z; Sun Z; Jiao B; Li K; Huang F; Hou X; Wang J; Shen L; Xia K; Tang B; Jiang H Neurobiol Aging; 2014 Sep; 35(9):2179.e15-8. PubMed ID: 24746364 [TBL] [Abstract][Full Text] [Related]
8. Preimplantation Genetic Testing of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease-Robust Tools for Direct and Indirect Detection of the Lian M; Tan VJ; Taguchi R; Zhao M; Phang GP; Tan AS; Liu S; Lee CG; Chong SS Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125643 [TBL] [Abstract][Full Text] [Related]
9. Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3. Gao R; Liu Y; Silva-Fernandes A; Fang X; Paulucci-Holthauzen A; Chatterjee A; Zhang HL; Matsuura T; Choudhary S; Ashizawa T; Koeppen AH; Maciel P; Hazra TK; Sarkar PS PLoS Genet; 2015 Jan; 11(1):e1004834. PubMed ID: 25590633 [TBL] [Abstract][Full Text] [Related]
10. Six cases of SCA3/MJD patients that mimic hereditary spastic paraplegia in clinic. Wang YG; Du J; Wang JL; Chen J; Chen C; Luo YY; Xiao ZQ; Jiang H; Yan XX; Xia K; Pan Q; Tang BS; Shen L J Neurol Sci; 2009 Oct; 285(1-2):121-4. PubMed ID: 19608203 [TBL] [Abstract][Full Text] [Related]
11. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds. Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629 [TBL] [Abstract][Full Text] [Related]
12. Does DNA methylation in the promoter region of the ATXN3 gene modify age at onset in MJD (SCA3) patients? Emmel VE; Alonso I; Jardim LB; Saraiva-Pereira ML; Sequeiros J Clin Genet; 2011 Jan; 79(1):100-2. PubMed ID: 21143471 [No Abstract] [Full Text] [Related]
13. [Clinical features and gene mutation analysis in Machado-Joseph disease of spinocerebellar ataxia type 3 in littoral of Zhejiang]. Jin YY; Zeng AP; Cai HB; Wu F; Feng Z; Hong Q; Zhang L; Jiang ZK Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):132-4. PubMed ID: 20104758 [TBL] [Abstract][Full Text] [Related]
14. The role of the mammalian DNA end-processing enzyme polynucleotide kinase 3'-phosphatase in spinocerebellar ataxia type 3 pathogenesis. Chatterjee A; Saha S; Chakraborty A; Silva-Fernandes A; Mandal SM; Neves-Carvalho A; Liu Y; Pandita RK; Hegde ML; Hegde PM; Boldogh I; Ashizawa T; Koeppen AH; Pandita TK; Maciel P; Sarkar PS; Hazra TK PLoS Genet; 2015 Jan; 11(1):e1004749. PubMed ID: 25633985 [TBL] [Abstract][Full Text] [Related]
15. Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice. Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Hirai H; Déglon N; de Almeida LP PLoS One; 2013; 8(1):e52396. PubMed ID: 23349684 [TBL] [Abstract][Full Text] [Related]
16. Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics. Paulino R; Nóbrega C Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108570 [TBL] [Abstract][Full Text] [Related]
19. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon. Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897 [TBL] [Abstract][Full Text] [Related]
20. Prenatal diagnosis of Machado-Joseph disease/Spinocerebellar Ataxia Type 3 in Taiwan: early detection of expanded ataxin-3. Tsai HF; Liu CS; Chen GD; Lin ML; Li C; Chen YY; Wang BT; Hsieh M J Clin Lab Anal; 2003; 17(5):195-200. PubMed ID: 12938149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]